MIAMI, FL, January 9, 2024 — Dr. Jeff Geschwind, renowned Director of Oncology at USA Clinics and Oncology Centers and Medical Director of Oncology and Image-Guided Therapy at NAMSA, is set to deliver one of the keynote addresses at the upcoming SPECTRUM Conference in Miami, Florida, from January 11-14, 2024.
The conference, a highly anticipated gathering of medical professionals, will feature a multidisciplinary session focused on the management of hepatocellular carcinoma (HCC). Dr. Geschwind’s lecture will specifically address the impact of conventional TACE (Transarterial Chemoembolization) on patients with HCC. Recognized globally as a leading expert on HCC, Dr. Geschwind has been instrumental in pioneering new therapies and establishing cone beam CT as the standard of care for intraarterial procedures in liver cancer.
With nearly 300 published manuscripts in prestigious journals, numerous awards, research grants and lectures throughout the world, and an impressive Google Scholar H-index of 84, Dr. Geschwind’s contributions have significantly advanced the field of interventional oncology and radiology. He organized the first World Conference on Interventional Oncology in 2005 and was the first president of the Society of Interventional Oncology.
The SPECTRUM Conference promises to be a unique and enriching experience for attendees, offering over 70 lectures, hands-on workshops, and panel discussions. The HCC session, featuring Dr. Geschwind, will provide a comprehensive overview of the latest developments in HCC management, emphasizing:
● Diverse Content: The program covers various facets of HCC management, providing a holistic understanding of the latest developments in the field.
● Global Thought Leaders: Dr. Jeff Geschwind and other leading medical professionals will share their perspectives, experiences, and expertise in a collaborative and multidisciplinary environment.
● Interactive Learning: Attendees will engage in hands-on workshops and panel discussions, encouraging interactive learning and facilitating a deeper understanding of the subject matter. The distinguished faculty assembled for the HCC session includes global experts in the
field. Following the session, attendees will have the unique opportunity to participate in a 1-hour multidisciplinary tumor board, fostering discussions and collaborative problem-solving.
SPECTRUM is a leading platform that brings together experts from various disciplines to advance knowledge and innovation in healthcare. The conference serves as a hub for experts from various disciplines to exchange ideas and best practices in healthcare. With a commitment to multidisciplinary collaboration, SPECTRUM hosts events, sessions, and conferences to facilitate the exchange of ideas and best practices in healthcare.
For media inquiries or further information, please contact:
Jeff Geschwind, MD
Director of Oncology
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Stock Invest journalist was involved in the writing and production of this article.